Netherlands· NL-6b082f05185c
Saflutan 15 microgram/ml oogdruppels, oplossing, verpakking voor eenmalig gebruik
A tafluprost product containing tafluprost, registered in Netherlands by BModesto B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tafluprost is registered in 16 of 19 countries.
Countries holding a registration under ATC S01EE05 (tafluprost), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Tafluprost · ATC S01EE05
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TAFLUPROST
- Manufacturer
- BModesto B.V.
- Country
- Netherlands (NL)
- ATC code
- S01EE05
- ATC class
- Tafluprost
- Defined daily dose
- 0.1 ml, AT
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id130801//103823
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tafluprost in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatestafluprostMicro Labs Limited
- CzechiaTAFLOTANSanten OY, Tampere
- FinlandTaflotanOrifarm Oy
- BelgiumSaflutan 15 µg/mlSanten
- SwedenTaflotan 15 mikrogram/ml Ögondroppar, lösning i endosbehållareSanten Oy
- NorwayTaflotanSanten Oy
- PolandTaflotanSanten Oy
- IrelandSaflutan 15 micrograms/ml, eye drops, solution in single-dose containerPCO Manufacturing Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Saflutan
- Belgium · Saflutan
- Bulgaria · Taflotan, Тафлотан
- Cyprus · Saflutan, Taflotan
- Czechia · Taflotan
- Germany · Taflotan, Taflotan Sine
- Denmark · Taflotan, Taflotan Sine
- Estonia · Tafdera, Taflotan
- Spain · Saflutan, Taflotan
- Finland · Taflotan, Taflotan Sine
- France · Saflutan, Tafluprost Rph Pharmaceuticals
- United Kingdom (Northern Ireland) · Saflutan, Tafluprost Brown & Burk Uk
- Greece · Saflutan, Taflotan
- Croatia · Saflutan
- Hungary · Taflotan
- Ireland · Saflutan
- Iceland · Taflotan, Taflotan Sine
- Italy · Safluround, Saflutan
- Lithuania · Taflotan
- Luxembourg · Saflutan, Tafluprost Micro Labs
- Latvia · Taflotan
- Malta · Saflutan
- Norway · Taflotan, Taflotan Sine
- Poland · Taflotan, Taflotan Multi
- Portugal · Saflutan, Taflotan
- Romania · Saflutan
- Sweden · Taflotan, Taflotan Sine
- Slovenia · Saflutan
- Slovakia · Taflotan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/58cd8bab-1526-41ab-90c6-39b5fdc1a644 GET /v1/drugs/58cd8bab-1526-41ab-90c6-39b5fdc1a644?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h103823_smpc.pdf",
"strength": null,
"atc_label": "Tafluprost",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130801",
"excipients": [
"DINATRIUMEDETAAT 2-WATER",
"GLYCEROL (E 422)",
"NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
"NATRIUMHYDROXIDE (E 524)",
"POLYSORBAAT 80 (E 433)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"TAFLUPROST"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130801.pdf",
"authorised_at": "2023/02/21",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "130801//103823",
"additional_monitoring": "N"
}See everything about tafluprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.